Skip to main content
. 2024 Aug 29;11:1421025. doi: 10.3389/fcvm.2024.1421025

Table 3.

Characteristics of enrolled acute myocardial infarction patients in IVUS guided and OCT guided group.

Variables IVUS N = 483 OCT N = 201 P-value
Baseline Characteristics
Male 396 (82.0%) 168 (83.5%) 0.866
Age 60.5 ± 10.5 63.5 ± 11.3 0.001
Hypertension 245 (50.7%) 93 (46.3%) 0.782
Diabetes 103 (21.3%) 53 (26.3%) 0.573
Hyperlipidemia 135 (28.0%) 72 (35.8%) 0.239
CKD/ESRD 110 (22.7%) 47 (23.4%) 0.722
Smoker 177 (36.6%) 64 (31.8%) 0.261
Clinical presentation
NSTEMI 284 (58.8%) 118 (58.7%) 0.922
STEMI 200 (41.4%) 82 (40.7%) 0.902
Cardiac History
History of MI (>3M) 24 (5.0%) 15 (7.5%) 0.207
History of CHF 24 (5.0%) 14 (7.0%) 0.424
Prior PCI 25 (5.2%) 13 (6.5%) 0.653
LVEF (%) 52.5 ± 10.1 50.5 ± 9.3 0.592
Number of Vessel disease 0.001
Single 251 (52.0%) 76 (37.8%)
Double 168 (34.8%) 82 (40.8%)
Triple 64 (13.3%) 43 (21.4%)
Targeted Vessel
LM 18 (3.7%) 20 (10.0%) 0.013
LAD 308 (63.8%) 120 (59.7%) 0.373
LCX 71 (14.7%) 57 (28.4%) <0.001
RCA 215 (44.5%) 91 (45.3%) 0.872
Procedural characteristics
Number of stents 2.7 ± 1.1 3.1 ± 1.2 0.382
Stent length 22.6 ± 6.2 24.2 ± 7.1 0.362
DES 385 (79.7%) 151 (75.1%) 0.862
BMS 98 (20.3%) 50 (24.9%)
Laboratory data
T. Cholesterol (mg/dl) 157.1 ± 42.5 159.1 ± 41.2 0.322
LDL-C (mg/dl) 92.1 ± 32.1 95.2 ± 32.2 0.431
eGFR 59.1 ± 22.1 58.1 ± 23.3 0.760
HbA1c 6.80 ± 1.61 6.88 ± 1.28 0.769

BMS, bare metal stent; CHF, congestive heart failure; CKD/ESRD, chronic kidney disease/end stage renal disease; DES, drug eluting stent; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1C; LAD, left anterior descending coronary artery; LCX, left circumflex coronary artery; LDL-C, low density lipoprotein cholesterol; LM, left main coronary artery; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NSTEMI, non ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; STEMI, ST segment elevation myocardial infarction.